Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1992 1
1993 1
1995 1
1998 2
2000 4
2001 2
2002 2
2004 1
2005 1
2006 1
2007 1
2008 2
2009 1
2010 1
2011 2
2012 1
2013 1
2019 3
2021 2
2022 1
2023 4
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study.
García-Corbacho J, Indacochea A, Victoria I, Moreno D, Angelats L, González Navarro AE, Mezquita L, Brasó-Maristany F, Galván P, Mellado B, Viñolas N, Sauri T, Nogué M, Adamo B, Maurel J, Pineda E, Gaba L, Reig O, Basté N, Sanfeliu E, Juan M, Prat A, Schettini F. García-Corbacho J, et al. Among authors: nogue m. Cancer Immunol Immunother. 2025 Feb 1;74(3):85. doi: 10.1007/s00262-024-03933-w. Cancer Immunol Immunother. 2025. PMID: 39891724 Free PMC article.
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.
Pesántez D, Ten Hoorn S, Machado I, García-Albéniz X, Rodríguez-Salas N, Heredia-Soto V, Viñal D, Pericay C, García-Carbonero R, Losa F, Alonso V, Vera R, Feliu Batlle J, Gallego J, Salud A, Nogué M, Layos L, Montagut C, Capdevila J, Vermeulen L, Maurel J, Fernandez-Martos C. Pesántez D, et al. Among authors: nogue m. J Natl Cancer Inst. 2023 Dec 6;115(12):1497-1505. doi: 10.1093/jnci/djad120. J Natl Cancer Inst. 2023. PMID: 37405857 Clinical Trial.
Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
Trilla-Fuertes L, Gámez-Pozo A, Nogué M, Busquier I, Arias F, López-Campos F, Fernández-Montes A, Ruiz A, Velázquez C, Martín-Bravo C, Pérez-Ruiz E, Asensio E, Hernández-Yagüe X, Rodrigues A, Ghanem I, López-Vacas R, Hafez A, Arias P, Dapía I, Solís M, Dittmann A, Ramos R, Llorens C, Maurel J, Campos-Barros Á, Fresno Vara JÁ, Feliu J. Trilla-Fuertes L, et al. Among authors: nogue m. Cancer. 2023 Aug 15;129(16):2581-2592. doi: 10.1002/cncr.34797. Epub 2023 Apr 25. Cancer. 2023. PMID: 37096763 Free article.
Second-line chemotherapy for non-small cell lung cancer.
Bonfill X, Serra C, Sacristán M, Nogué M, Losa F, Montesinos J. Bonfill X, et al. Among authors: nogue m. Cochrane Database Syst Rev. 2002;(2):CD002804. doi: 10.1002/14651858.CD002804. Cochrane Database Syst Rev. 2002. PMID: 12076452
Persistent COVID-19 symptoms 1 year after hospital discharge: A prospective multicenter study.
Aranda J, Oriol I, Feria L, Abelenda G, Rombauts A, Simonetti AF, Catalano C, Pallarès N, Martín M, Vàzquez N, Vall-Llosera E, Rhyman N, Suárez RC, Nogué M, Loureiro-Amigo J, Coloma A, Ceresuela L, Carratalà J. Aranda J, et al. Among authors: nogue m. PLoS One. 2022 Oct 10;17(10):e0275615. doi: 10.1371/journal.pone.0275615. eCollection 2022. PLoS One. 2022. PMID: 36215250 Free PMC article.
[Tobacco and health].
Nogue MR. Nogue MR. Vie Med Can Fr. 1973 Jan;2(1):21-32. Vie Med Can Fr. 1973. PMID: 4711742 French. No abstract available.
36 results